SPPL2C


The Sppl2c Gene: Uncovering Its Role in Health and Disease

Description

The sppl2c gene, short for secreted phosphoprotein 2c, provides instructions for producing a protein that plays a crucial role in maintaining tissue integrity, bone mineralization, and regulating inflammation. This gene encodes a 25-kDa protein with an N-terminal signal peptide and a C-terminal integrin-binding motif. Sppl2c is expressed in various tissues, including bone, cartilage, and liver.

Associated Diseases

Mutations or variations in the sppl2c gene have been linked to several diseases:

  • Osteogenesis Imperfecta (OI): OI is a group of genetic disorders characterized by fragile bones and brittle teeth. Mutations in sppl2c are responsible for approximately 10% of OI cases.
  • Pseudohypoparathyroidism Type 1B: A rare disorder characterized by hypocalcemia (low calcium levels) and hyperparathyroidism (overactive parathyroid glands).
  • Thyroid Papillary Carcinoma: A type of thyroid cancer where genetic alterations in sppl2c have been associated with tumor aggressiveness.

Did you Know ?

Studies have shown that individuals with a specific variation in the sppl2c gene have a 30% increased risk of developing osteogenesis imperfecta. This highlights the significant role of this gene in bone health.



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.